InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+0.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Armitage James O, Director. Insider active across 1 company, notably Cardiff Oncology, Inc.. Cumulatively, 2 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €57k. History available since 19 March 2021. The latest transaction was filed on 16 September 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Armitage James O
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
13,000 shares@ US$1.556421.8% of flowCommon StockSEC:0001628280-22-026245:0
Canonical exit: 15 Dec 2022 (T+90)
4,000 shares@ US$10.817864.2% of flowCommon StockSEC:0001628280-21-011230:0
Canonical exit: 17 Jun 2021 (T+90)
2 of 2 declarations
About Armitage James O
James O. Armitage is a Board Member at Cardiff Oncology, Inc. He plays a key role in the governance of the company, influencing strategic decisions and contributing to its development.
